Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Leopold Sellner*, Johannes Schetelig, Linda Koster, Goda Choi, Didier Blaise, Dietrich Beelen, Fabrizio Carnevale Schianca, Jakob Passweg, Urs Schanz, Emmanuel Gyan, Federica Sora, Nicolaus Kröger, Gerald G Wulf, Gwendolyn Van Gorkom, Jiri Mayer, Corentin Orvain, Jean Henri Bourhis, Pavel Jindra, Victoria PotterFrancesco Zallio, Elisabeth Vandenberghe, Stephen Robinson, Patrick J Hayden, Ibrahim Yakoub-Agha, Silvia Montoto, Peter Dreger

*Corresponding author for this work

    Research output: Contribution to journalLetterAcademicpeer-review

    1 Citation (Scopus)
    Original languageEnglish
    Pages (from-to)2335-2338
    Number of pages4
    JournalBone marrow transplantation
    Issue number12
    Early online date2020
    DOIs
    Publication statusPublished - 22-May-2020

    Keywords

    • RITUXIMAB
    • INHIBITION
    • OUTCOMES
    • TRIAL

    Cite this